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Interaction between SecA and SecYEG in Micellar Solution and Formation of the
Membrane-Inserted State†
Chris van der Does, Erik H. Manting, Andreas Kaufmann, Marco Lutz, and Arnold J. M. Driessen*
Department of Microbiology and Groningen Biomolecular Sciences and Biotechnology Institute, UniVersity of Groningen,
Kerklaan 30, 9751 NN Haren, The Netherlands
ReceiVed August 25, 1997; ReVised Manuscript ReceiVed October 22, 1997X
ABSTRACT: Preprotein translocation in Escherichia coli is mediated by the translocase with SecA as
peripheral ATPase and SecY, SecE, and SecG as membrane domain. To facilitate large-scale purification
of the SecYEG heterotrimer, SecY was fused at its amino terminus with a hexahistidine tag and co-
overexpressed with SecE and SecG. The presence of the His tag allowed purification of homogeneously
pure SecYEG complex by a single anion-exchange chromatographic step starting from octyl glucoside-
solubilized inner membranes. Endogenous levels of SecD and SecF copurified with the SecYEG protein.
Purified SecYEG complex retained a nativelike, R-helical conformation in octyl glucoside and in micellar
solution binds SecA with high affinity. In the presence of the nonhydrolyzable nucleotide analogue
adenosine 5′-(â,ç-imidotriphosphate), octyl glucoside-solubilized SecYEG is nearly as effective as the
reconstituted enzyme in inducing the formation of a proteinase K-protected 30 kDa fragment of 125I-
labeled SecA, while SecYEG is proteolyzed to fragments smaller than 6 kDa. These data demonstrate
that the 30-kDa SecA fragment is not protected by the lipid phase nor by SecYEG but rather indicate that
it represents a SecYEG- and nucleotide-induced stable conformational state of a SecA domain.
The last decade has seen a major advance in the study of
bacterial protein translocation (for reviews see refs 1 and
2). The components involved in the translocation reaction
have been genetically identified and biochemically purified,
and the translocation reaction as it proceeds across the inner
membrane of Escherichia coli has been reconstituted in
liposomes using purified components (3, 4). The general
secretion pathway in E. coli consists of a cytoplasmic
chaperone, SecB (5), a peripherally membrane-associated
ATPase, SecA (6), and five inner membrane proteins, i.e.,
SecY (7), SecE (8), SecG (9), SecD, and SecF (10, 11). The
minimal requirements for preprotein translocation across the
inner membrane are met by SecA, SecY, and SecE, which
together with SecG form the translocase (3). SecG enhances
the fidelity of the SecYE reconstituted protein translocation
reaction at least 20-fold (9), while secG null strains are cold-
sensitive for growth (12). SecD and SecF are integral
membrane proteins that expose large hydrophilic domains
to the periplasmic space (10, 11, 13). SecD and secF null
strains are also cold-sensitive (13). SecY, SecE, and SecG
can be immunoprecipitated, isolated, and purified as a stable
heterotrimeric complex (3, 14). Genetic evidence suggests
that SecY and SecE are dissociable subunits (15), but
biochemical evidence suggests that they interact stably once
assembled in the membrane (16). Together SecY and SecE
suffice to constitute a high-affinity membrane binding site
for SecA (14, 17). Recent evidence suggests that the proteins
encoded by the secD operon, i.e., SecD, SecF, and YajC,
also form a heterotrimeric complex that associates with the
SecYEG complex to form a large hexameric integral
membrane protein domain (SecYEGDFYajC) that is stable
in the mild detergent digitonin (14). Stabilization by
overexpression (18, 19) experiments indicate that SecG and
SecE interact with SecY, while SecF interacts with SecD
and SecY. YajC is a dispensable protein that has no known
function in protein export (11). When present on a high-
copy plasmid, it suppresses the SecY-d mutation and causes
impaired growth of the SecY39 mutant at 42 °C (20). SecD
and SecF have been implicated in the maintenance of
protonmotive force (¢p) across the cytoplasmic membrane
(21), in the release of translocated proteins in the periplasmic
space (22), and in the stabilization of membrane-inserted
SecA (14, 23). Overexpression of SecD and SecF restores
the translocation of preproteins with a defective signal
peptide (13).
SecA is a dissociable subunit of the translocase and exists
both in free cytosolic forms and as membrane-bound forms
(24). SecA interacts in a nonsaturable manner with acidic
phospholipids (25) and binds with high affinity to the SecY
subunit of the SecYEG complex (14, 17, 26, 27). SecYEG-
bound SecA exhibits a high affinity for the binary SecB-
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preprotein complex and recognizes the preprotein by inter-
acting with both the signal sequence and the mature domain
of the preprotein (25, 28). SecA is a preprotein-stimulated
ATPase (29), which in the presence of acidic phospholipids
and SecYEG is activated for ADP-ATP exchange (3, 29).
Binding of ATP elicits a conformational change (30) that
releases SecB into the cytosol (31) and promotes insertion
of a SecA carboxyl-terminal domain into the membrane (23,
32, 33). At the same time, limited translocation of SecA-
bound preprotein polypeptide segments occurs (34). SecA
releases the bound preprotein upon the hydrolysis of ATP
(34), concomitantly with the deinsertion of the SecA domain
from the membrane (32). Repeated cycles of ATP binding
and hydrolysis coupled to the membrane insertion and
deinsertion of SecA at the SecYEG complex ultimately allow
the stepwise translocation of the preprotein across the
membrane (34-36). ¢p stimulates the rate of translocation
(37).
The preprotein translocation reaction across the inner
membrane of E. coli shares many characteristics with that
of the eukaryotic endoplasmic reticulum (for reviews see refs
38 and 39). The quaternary organization of the mammalian
and yeast endoplasmic reticulum translocase largely re-
sembles that of the SecYEG complex of E. coli. The
mammalian Sec61p complex consists of three subunits, i.e.,
Sec61R, Sec61â, and Sec61ç. Sec61R and Sec61ç are
homologous to the bacterial SecY and SecE, respectively,
while Sec61â has a similar organization as SecG but is not
homologous. The mammalian Sec61p complex is found
associated with the TRAM protein, which so far has no
known homologues in bacteria. In yeast, also a posttrans-
lational translocase has been identified, which in addition
to Sec61 (Sec61R in mammals), Sbh1 (Sec61â in mammals),
and Sss1 (Sec61ç in mammals), involves Sec62, Sec63,
Sec71, and Sec72 (40). Yeast does not contain a SecA
homologue, but lumenal BiP (Hsp70) couples the hydrolysis
of ATP to the translocation of preproteins into the ER lumen.
These complexes have been purified to homogeneity (40,
41), and investigated by high-resolution electron microscopy,
which shows ringlike structures, suggesting that the mem-
brane domain consists of 3-4 Sec61p trimers with a central
pore (42). The translocation pore of the mammalian Sec61p
complex may have a diameter of 40-60 Å during protein
translocation (43). A low-resolution structure of the bacterial
SecYEG complex is not yet available.
The SecYEG complex can be purified from wild-type cells
(3) or as separate, isolated subunits from overproducing
strains (44). To facilitate studies on the structure and
function of the bacterial translocase, we have developed a
rapid purification protocol that permits isolation of milligram
amounts of functional SecYEG protein using membranes
derived from an E. coli strain that overexpresses the SecYEG
complex with a His tag on SecY. The catalytic and
functional properties of the SecYEG complex have been
analyzed in micellar solution in the absence of compartmen-
talization. The solubilized complex binds stoichiometrical
amounts of SecA with high affinity and, more strikingly,
supports the nucleotide-induced formation of a 30 kDa
proteinase-protected fragment of SecA that is thought to be
membrane-integrated. Since the SecYEG complex is de-
graded under these conditions, it appears that this SecA
fragment is not protected by the lipid bilayer nor by a
transmembrane shell of SecYEG protein but rather represents
a stable conformation of a SecA domain induced by its
interactions with SecYEG and nucleotides.
EXPERIMENTAL PROCEDURES
Materials. E. coli SecA (6), SecB (45), and proOmpA
(46) were purified as described. 35S-Labeled proOmpA was
synthesized by in Vitro transcription/translation, affinity-
purified (47), and stored frozen in 6 M urea and 50 mM
Tris-HCl, pH 7.8. pAbs were raised against synthetic
peptides that correspond to domains of SecG (H2N-APAK-
TEQTQP) (Research Genetics Inc., Huntsville, AL) (R-SecG
IgG), YajC (H2N-YRPQQKRTKEHKKLMDS), SecD (H2N-
KEELSNGRTVQQAIDEGYRG) (R-SecD IgG), and SecF
(H2N-MAQEYTVEQLNHGRKC) (R-SecF IgG) (Neosystem
Laboratoire, Strassbourgh, France) as conjugates of bovine
serum albumin (BSA). The pAb against leader peptidase
(R-Lep IgG) was a generous gift of W. Wickner (Dartmouth
College, Hanover, NH). E. coli lipids (Avanti Polar lipids,
Inc., Brimingham, AL) were washed with acetone and ether
(48) and suspended at 20 mg/mL in water containing 1 mM
dithiothreitol (DTT).
Plasmid Construction. The vector pET340 (SecYEG+)
allows the overproduction of SecYEG under control of the
isopropyl â-D-thiogalactopyranoside-(IPTG-) inducible trc
promoter (49) and contains an ampicillin resistance gene and
colE1 origin. The construction of plasmids overproducing
the SecYEG complex with a hexahistidine tag at the amino
terminus of SecY (pET349; SechYnEG+) and SecE (pET320;
SecYhEnG+) and the carboxy-terminus of SecY (pET512;
SechYcEG+) has been described previously (26). The hexa-
His tag followed (or preceded, in the case of the carboxy-
terminal tag) by an enterokinase recognition site contains
the amino acids sequence MH6E4KA. As a control plasmid,
the linking sequence coding for the His tag and enterokinase
site (26) was inserted in pET324 (49), resulting in pET302.
All constructs were confirmed by sequence analysis on a
Vistra DNA sequencer 725 using the automated ¢taq
sequencing kit (Amersham, Buckinghamshire, U.K.). All
other DNA techniques followed standard procedures (51).
Bacterial Strains and Growth Conditions. For all experi-
ments, the OmpT and OmpP (A.K., unpublished results)
protease-deficient strain SF100 (52) was used. Strains were
grown aerobically at 37 °C on L-broth in a shaking incubator
until the end of the logarithmic phase. Ampicillin was used
at 50 íg/mL. For the induction of plasmid-encoded genes
under control of an IPTG-inducible promoter, exponentially
growing cultures were supplemented with 0.5 mM IPTG at
an OD660 of 0.5 and grown for another 2 h. Large-scale
production of cells was done in a 15-L fermenter (ADI 1065
Biobench, Applikon, The Netherlands) on L-broth supple-
mented with 1% glycerol. At an OD660 of about 4, cells
were induced for 2 h, collected by centrifugation, resus-
pended into 20% sucrose and 50 mM Tris-HCl, pH 8.0, and
frozen as nuggets in liquid nitrogen.
Isolation of Inner Membrane Vesicles. Cells were quickly
thawn at 37 °C, and diluted with an equal volume of 20%
glycerol and 50 mM Tris-HCl, pH 8.0 (buffer A) supple-
mented with 1 mg/mL DNase and RNase and 1 mM
phenylmethanesulfonyl fluoride. The suspension was sub-
jected to French press treatment (4 times at 8000 psi), diluted
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with an equal volume of buffer A, and cleared from debris
by centrifugation (10 min at 4000g). Membranes were
isolated from the supernatant by centrifugation (90 min at
40000g), resuspended in buffer A, and applied onto a 30-
60% sucrose gradient in 50 mM Tris-HCl, pH 8.0. After
18 h, IMVs were collected, diluted with 5 volumes of buffer
A, and recollected by centrifugation (90 min at 40000g).
Purified IMVs were resuspended in buffer A at 20 mg/mL
and stored in liquid nitrogen.
Solubilization and Purification of SecYEG. SechYnEG+
or SechYcEG+ IMVs (60 mg of protein) were solubilized
on ice for 20 min at 1 mg/mL in 1.25% n-octyl â-D-
glucopyranoside (octyl glucoside), 10 mM Tris-HCl, pH 8.0,
20% glycerol, 0.5 mg/mL E. coli lipids, and 5 mM p-
aminobenzamidine (buffer B). Nonsolubilized proteins and
aggregates were removed by centrifugation (30 min at
40000g), and the cleared supernatant was loaded onto a
DEAE column (volume 60 mL) (Whatman, DE-52) equili-
brated with buffer B. The column was washed with 2
volumes of buffer B, and proteins were eluted with a linear
KCl gradient (0-300 mM) in 3 volumes of buffer B. The
ionic strength of the elution was monitored continuously with
a conductivity monitor (Pharmacia Biotech, Uppsala, Swe-
den). Fractions of 6 mL were collected, immediately sup-
plemented with 87% glycerol and 1.25% octyl glucoside to
yield a final glycerol concentration of 40%, and stored at
-18 °C. Fractions were analyzed by SDS-15% PAGE
(sodium dodecyl sulfate-polyacylamide gel electrophoresis)
(53) and stained with Coomassie brilliant blue (CBB).
Immunoblotting was performed using a semidry blotter
(Transblot-SD, Bio-Rad Laboratories, Hercules, CA), and
blots were developed using several different pAbs and
p-nitroblue tetrazolium chloride/sodium 5-bromo-4-chloro-
indolyl phosphate staining (Boehringer Mannheim, Mann-
heim, Germany) of alkaline phosphatase-conjugated second-
ary antibody (Boehringer Mannheim, Mannheim, Germany).
Preparation of Polyclonal Antibodies Directed against
SecY and SecE. To obtain pAbs directed against purified
SecY and SecE, membranes were isolated from E. coli strain
SF100 harboring pET320 (SecYhEnG+) or pET349 (Sech-
YnEG+), respectively. His-tagged proteins were purified
from the octyl glucoside-solubilized IMVs by Ni2+-NTA
affinity chromatography using a HiTrap chelating column
(Pharmacia Biotech) and a buffer containing 100 mM NaCl
and 50 mM NaPi, pH 8.0, and a gradient of 0-500 mM
imidazole. Fractions containing SecY and SecE were
separated on a preparative 15% polyacrylamide gel, and
individual proteins were excised from the gel and collected
by electroelution (Electro-Eluter, Bio-Rad Laboratories,
Hercules, CA). Purified proteins (over 99% pure as checked
by SDS-PAGE followed by CBB staining) were used as
antigens to immunize rabbits to yield pAbs against the His-
tagged SecY (R-SecY IgG) and SecE (R-SecE IgG).
Reconstitution of SecYEG into Liposomes. The SechYnEG
complex was reconstituted into liposomes by a modification
of the detergent dilution technique (3). Solubilized SechYnEG
(100 íL; 0.25-0.5 mg/mL) was mixed with 20 íL of E.
coli lipids (20 mg/mL) and incubated for 5 min on ice. The
sample was diluted into 4 mL of buffer containing 50 mM
Tris-HCl, pH 8.0, and 50 mM KCl, and after 5 min of
incubation, proteoliposomes were collected by centrifugation
(30 min, SW-28 rotor, 50 000 rpm, 4 °C) and resuspended
in 100 íL of 50 mM Tris-HCl, pH 8.0, and 50 mM KCl.
Reconstituted SechYnEG proteoliposomes were frozen and
stored in liquid nitrogen. Before use, samples were thawed
at 37 °C and sonicated 3 times for 10 s in a bath sonicator.
Translocation and SecA Translocation ATPase Assays.
Translocation of 35S-proOmpA into proteoliposomes was
assayed by its accessibility to added proteinase K (54).
Reaction mixtures (50 íL) contained buffer D [50 mM
HEPES-KOH, pH 7.5, 30 mM KCl, 0.5 mg/mL BSA, 2 mM
DTT, and 2 mM Mg(OAc)2], 1.6 íg of SecB protein, 0.5
íg of SecA, 2 mM ATP, 10 mM creatine phosphate, and
0.5 íg of creatine kinase. Based on quantitative immunoblot
analysis, reactions were supplemented with approximately
equal amounts of SecY, i.e., with SechYnEG proteolipo-
somes (20 íg/mL) or SechYnEG+ IMVs (100 íg/mL). 35S-
proOmpA was diluted 50-fold from a solution containing 6
M urea and 50 mM Tris-HCl, pH 7.8. Translocation
reactions were performed at 37 °C, and at various times,
samples were taken, chilled on ice, and treated with pro-
teinase K (0.1 mg/mL) for 15 min. Samples were analyzed
by SDS-12% PAGE and quantified with the â-imager 2000
(Biospace Measures, Paris, France).
Translocation ATPase activity of urea-treated inner mem-
branes or SecYEG proteoliposomes was measured with
proOmpA as described (29).
Circular Dichroism Spectroscopy. Circular dichroism
(CD) spectra of octyl glucoside-solubilized or reconstituted
SechYnEG protein (95 íg/mL) were recorded in 10 mM
NaPi, pH 7.8, 10 mM KCl, and 1 mg/mL E. coli lipids. CD
spectra of SecA (168 íg/mL) were determined in 10 mM
NaPi, pH 7.6, 10 mM KCl and 2 mM MgCl2 in the absence
and presence of 1.25% octyl glucoside. Measurements were
performed with an Aviv CD spectrophotometer, Model 62a
DS. The measuring cell was thermostated at 4 °C. Spectra
were corrected for the lipid and detergent contributions and
deconvoluted with the SELCON software package (55).
Enterokinase Digestion of His-Tagged SecY. The acces-
sibility of the introduced enterokinase site at the amino
terminus of SecY was determined as follows: solubilized
or reconstituted SechYnEG complex (50 íg/mL) was
incubated at 20 °C in a buffer (30 íL) containing 20 mM
Tris-HCl, pH 8.0, 50 mM NaCl, and 2 mM CaCl2. To the
samples, varying amounts of SecA or BSA were added, and
after 10 min, the mixture was supplemented with 1 unit of
enterokinase (New England Biolabs, Beverly, MA) and
incubated for 1 h. Reactions were terminated by the addition
of SDS sample buffer and analyzed by SDS-15% PAGE
followed by CBB staining or immunoblotting using the pAbs
directed against His-tagged SecY or SecE.
Formation of the 125I-Labeled 30 kDa Fragment of SecA.
Purified SecA was labeled with carrier-free 125I as described
(32, 56). 125I-SecA (2.5 ng/mL) was incubated on ice in
buffer D containing either SechYnEG+ IMVs (0.5 íg/mL)
or purified SechYnEG (50 ng/mL) reconstituted into pro-
teoliposomes or present in octyl glucoside solution. Incuba-
tions were performed with or without 1.25 mM adenosine
5′-(â,ç-imidotriphosphate) (AMP-PNP), and in the case of
the solubilized SechYnEG, the buffer was supplemented with
1.25% octyl glucoside or 1% Triton X-100.. After 30 min,
samples were treated with proteinase K (0.04-1 mg/mL)
for 15 min on ice, precipitated with 7.5% (w/v) trichloro-
acetic acid, washed with acetone, and solubilized in SDS
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sample buffer. Samples were separated by 12% PAGE and
analyzed by autoradiography and â-imaging.
125I-Labeling and Proteolysis of Purified SechYnEG Com-
plex. Reconstituted SechYnEG protein (10 íg) in 50 mM
KCl and 50 mM Tris-HCl, pH 8.0 (100 íL), was photo-
affinity-labeled with 13.3 íCi of 3-(trifluoromethyl)-3-(m-
[125I]iodophenyl)diazirine (125I-TID) (Radiochemical centre,
Amersham, U.K.) for 2 min at 0 °C with a 254 nm lamp
(Model UVG-54, UVP Life Sciences Inc., Cambridge, U.K.)
placed at a distance of 1 cm.
For proteolysis experiments, proteoliposomes bearing
nonlabeled or 125I-TID SechYnEG (0.5 íg), or solubilized
SechYnEG complex, were incubated for 30 min at 4 °C in
buffer D (50 íL) in the absence or presence of 1.25% octyl
glucoside, 1.25 mM AMP-PNP, and/or 20 íg/mL of SecA
protein. Subsequently, samples were incubated with pro-
teinase K (1 mg/mL) for 15 min at 4 °C, solubilized in SDS
sample buffer, separated on 16% Tricine gels (57), and
analyzed by silver and CBB staining, autoradiography, or
by western blotting using R-SecY IgG.
Other Analytical Techniques. Protein concentrations were
determined by the method of Lowry (58) in the presence of
SDS using BSA as a standard. The SecYEG concentration
was estimated from quantitative total amino acid determi-
nation performed by Eurosequence (Groningen, The Neth-
erlands). SecA protein concentrations were determined
spectrophotometrically at 280 nm using an extinction coef-
ficient () of 90.85 mM-1 cm-1 (T. den Blaauwen, personal
communication).
RESULTS
Purification of Functional SecYEG Complex. To simplify
the purification of the SecYEG complex from an overpro-
ducing strain (49), affinity purification of the complex with
His-tagged SecY or SecE on Ni2+-NTA columns was tried.
For this purpose, vectors were used that express the secYEG
genes in tandem with a hexahistidine tag and cleavable
enterokinase site at either the amino- or carboxyl terminus
of SecY (Table 1; 26). The His-tagged SecY protein can
be co-overexpressed to high levels together with SecE and
SecG as shown by CBB staining of an SDS-polyacrylamide
gel loaded with SechYnEG+ IMVs (Figure 1A). We have
previously shown that the His tag does not interfere with
the level of SecYEG overexpression, the proOmpA-
stimulated SecA translocation ATPase, and 35S-proOmpA
translocation into IMVs (26). Ni2+ affinity chromatography
Table 1: Plasmids Used in This Study
plasmid relevant characteristics source or reference
pET324 pTRC99A-derived vector containing lacZR behind the trc promoter 48
pET302 pET324-derived vector containing a His tag and an enterokinase site this work
pET340 pET324 with secYEG under control of the trc promoter 48
pET320 pET302 containing secYEG behind trc promoter with N-terminally His-tagged SecE 26
pET349 pET302 containing secYEG behind trc promoter with N-terminally His-tagged SecY 26
pET512 pET340 containing C-terminally His-tagged SecY 26
B
FIGURE 1: Co-overexpression of hexahistidine-tagged SecY with SecE, and SecG, and purification of the SecYEG complex. (A) CBB-
stained SDS-PAGE of IMVs derived from SF100 cells harboring plasmids pET324 (control) (lane 1) and pET349 (SechYnEG+) (lane 2).
(B and C) Octyl glucoside-solubilized SechYnEG+ IMVs were applied on a DEAE column and eluted with a linear gradient of 0-300 mM
KCl. Column fractions were analyzed by SDS-PAGE and CBB staining (B), and after reconstitution into liposomes by rapid dilution, they
were assayed for the SecA activity in the absence (solid bars) and presence (open bars) of proOmpA (C). The positions of the various Sec
proteins and molecular mass markers are indicated.
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with Triton X-100-, octyl glucoside-, or dodecyl maltoside-
solubilized IMVs resulted only in the purification of His-
tagged SecY or SecE protein with almost no detectable
copurification of other components of the SecYEG complex.
Moreover, E. coli phospholipids could not be included in
the elution buffer as they interfered with the binding of the
His-tagged proteins to the Ni2+-NTA resin. Previously, it
was shown that phospholipids are need to maintain the
SecYEG complex in an active state during solubilization and
reconstitution (59). Therefore, the conventional method for
purification of the SecYEG complex was attempted, which
is based on octyl glucoside solubilization of urea-treated
IMVs followed by three consecutive chromatographic steps
(3). Since the urea extraction reduced the efficiency of
solubilization, this step was eliminated and octyl glucoside-
extracted proteins were directly loaded on a DEAE column.
In contrast to the native complex, the SecYEG heterotrimer
with amino-terminally His-tagged SecY binds only weakly
to the column and elutes at a KCl concentration of about 10
mM in an essentially pure form (Figure 1B). Similar results
were obtained with carboxyl-terminally His-tagged SecY
(data not shown). In contrast, wild-type SecYEG complex
elutes at a KCl concentration of about 50-60 mM along
with most of the other membrane protein (3). For conven-
ience, the purified complex harboring the amino-terminally
His-tagged SecY is termed SechYnEG in the following
sections.
The identity of the protein bands in the purified fractions
was verified by the use of pAbs directed against the His-
tagged SecY and SecE proteins, a pAb raised against a
synthetic peptide corresponding to a SecG domain, and by
total amino acid analysis of the proteins excised from the
gel. In addition, minor amounts of two other proteins were
present that coelute with the SechYnEG protein. These
proteins, with apparent molecular masses of 54 and 27 kDa,
reacted with R-SecD and SecF antibodies, respectively.
Immunoblot analysis further showed that the purified
SechYnEG was devoid from YajC and leader peptidase (Lep)
that were recovered in the flowthrough and bulk protein
fractions, respectively (data not shown).
Column fractions were reconstituted by rapid dilution in
liposomes composed of E. coli lipids and analyzed for the
proOmpA-stimulated SecA translocation ATPase activity.
Only the fractions containing SechYnEG protein were active
in this assay (Figure 1C). Purification resulted in an almost
5-fold increase in the specific SecA ATPase activity, and
apparently without loss of activity (Table 2). When analyzed
at the same SecY content, proteoliposomes reconstituted with
SechYnEG proteoliposomes were nearly as active in the ATP
and SecA-dependent translocation of 35S-proOmpA as non-
urea-treated SechYnEG+ IMVs (Figure 2). The use of a His-
tagged SecY, therefore, allows for a rapid purification of
large quantities of functional SechYnEG complex with only
a minimal loss of activity.
Stability of the SecYEG Complex. To facilitate further
biochemical and biophysical research, the stability of the
detergent-solubilized SechYnEG was compared with the
reconstituted enzyme and with SechYnEG+ IMVs. For this
purpose, the SecA translocation ATPase activity was mea-
sured after incubation under different sets of conditions.
SechYnEG+ IMVs appeared highly stable, and hardly any
inactivation occurred after a 3 day incubation at 37 °C
(Figure 3). Reconstituted SechYnEG complex was stable
on ice and when stored at -20 °C or below but lost its
activity when incubated for longer periods of time at 25 and
37 °C. Finally, the purified SechYnEG complex in octyl
glucoside was stable only at 4 °C and below and was rapidly
inactivated at 37 °C (t1/2 ) 15-20 min) (Figure 3). For
stability, it was necessary that the glycerol concentration was
kept at 40% (v/v) and that at least 0.2 mg/mL E. coli lipids
are present. Under these conditions, it was possible to store
the purified complex for at least 7 months at -20 °C without
loss of activity.
Octyl Glucoside-Solubilized SecYEG Is in a Near-NatiVe,
R-Helical Conformation. The influence of octyl glucoside
on the secondary structure of SechYnEG was analyzed by
circular dichroism (CD) spectroscopy. The spectrum of
reconstituted SechYnEG is typical for an R-helical protein
(Figure 4A). Computational deconvolution of the CD
spectrum revealed an R-helical content of at least 83%,
indicating that the protein is largely in a nondenatured state.










SecYEG+ membranes 60 (100%) 7860 (100%) 131
DEAE pool 15 (25%) 8118 (103%) 580
a The percentage of recovery of SecA translocation ATPase is
indicated in parentheses.
FIGURE 2: Purified SechYnEG is reconstituted in an active state.
Time courses of the translocation of 35S-proOmpA into SechYnEG+
IMVs (A) and proteoliposomes reconstituted with purified
SechYnEG+ (B) in the presence of SecA and ATP are shown.
Samples contained identical amounts of SecY as determined by
quantitative immunoblotting. Positions of proOmpA and processed
OmpA are indicated.
FIGURE 3: Temperature stability of the SechYnEG complex. The
time courses of the remaining proOmpA-stimulated SecA ATPase
activity of (A) SechYnEG+ IMVs, (B) SechYnEG proteoliposomes,
and (C) solubilized SechYnEG protein after incubation at -20 °C
(b), 4 °C (O), 25 °C (9) and 37 °C (0) was measured as described
in the Experimental Procedures section. The SecA translocation
ATPase activity of SechYnEG+ IMVs stored in liquid nitrogen was
set to 100%.
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Although some loss of secondary structure seemed to occur,
the SechYnEG complex remained mainly R-helical (72%)
when solubilized in octyl glucoside. The CD spectrum of
SecA (Figure 4B) points at a high amount of â-structure
(55% â-sheet, 18% â-turn, and 18% R-helical). Octyl
glucoside (1.25%) hardly altered the spectrum (48% â-sheet,
16% â-turn, and 21% R-helical). These data indicate that
both SechYnEG and SecA maintain a nativelike secondary
structure when present in detergent solution.
Octyl Glucoside-Solubilized SecYEG Binds SecA with High
Affinity. To determine the orientation of reconstituted
SechYnEG, the accessibility of the enterokinase recognition
site at the amino terminus of SecY to externally added
enterokinase was analyzed in the absence and presence of
octyl glucoside. In the absence of octyl glucoside, entero-
kinase removes about 50% of the His tag from the recon-
stituted SecY protein (Figure 5, compare lanes 1 and 2), and
the tag is removed completely upon solubilization by
octylglucoside (lane 4). Immunoblot analysis of the samples
using a mAb directed against the His tag confirms that
enterokinase indeed removes the His tag from SecY (see
Figure 6B). The data suggest that SechYnEG is reconstituted
in a scrambled orientation.
Next, the ability of SecA to protect the His-tagged SecY
of SechYnEG proteoliposomes against enterokinase cleavage
was determined. Experiments were performed at 25 °C
where the SechYnEG complex is reasonably stable in
detergent solution when incubated for only short periods of
time, i.e., 30 min to 1 h (Figure 3C). When the amount of
BSA in the buffer was gradually replaced by SecA, protection
of the His-tagged SecY against proteolysis by enterokinase
occurred (Figure 6A, B). Strikingly, the same protective
effect of SecA was observed when the experiments were
performed in the presence of octyl glucoside to solubilize
the SechYnEG protein (Figure 6C, D). In the absence of
SecA, enterokinase completely removed the His tag from
SecY. On the other hand, full protection against proteolysis
was obtained when SecA monomer (0.95 íM) was added
in a slight excess relative to SecY (0.7 íM). The protective
effect of SecA on reconstituted and detergent-solubilized His-
tagged SecY was not influenced by nucleotides (ATP, AMP-
PNP, or ADP) and/or proOmpA. In contrast to the recon-
stituted enzyme, the solubilized SechYnEG did not support
SecA translocation ATPase activity (data not shown). These
data demonstrate that SechYnEG maintains the ability to bind
SecA with high affinity when present in detergent solution.
SecYEG-Dependent and Nucleotide-Induced Formation of
the SecA Membrane-Inserted State in Detergent Solution.
At 37 °C, in the presence of ATP and preprotein, the
SecYEG-bound SecA undergoes a conformational change
that results in the formation of a membrane-protected,
proteinase inaccessible 30 kDa carboxy-terminal domain (23,
32, 33). It has been suggested that this fragment corresponds
to a membrane-inserted domain of SecA. The 30 kDa SecA
fragment can also be formed without preprotein at 4 °C in
the presence of nonhydrolyzable ATP, i.e., AMP-PNP. To
FIGURE 4: Circular dichroism spectra of SechYnEG (A) and SecA
(B) in the absence (solid lines) and presence (dashed lines) of octyl
glucoside. Shown spectra were corrected for the lipid and detergent
contributions.
FIGURE 5: Orientation of SecY in reconstituted SechYnEG pro-
teoliposomes. The accessibility of the introduced proteolytic
enterokinase site at the amino-terminus of SecY toward purified
enterokinase was used to probe the orientation of SecY in the
reconstituted SechYnEG proteoliposomes. SechYnEG proteolipo-
somes were incubated in the absence (lanes 1 and 2) and presence
of 1.25% octyl glucoside (OG) (lanes 3 and 4) and, as indicated,
treated with enterokinase as described in the Experimental Proce-
dures section. Incubations were at 25 °C in a buffer containing 20
mM Tris-HCl, pH 8.0, 50 mM NaCl, and 2 mM CaCl2. After 1 h,
samples were analyzed by SDS-12% PAGE and CBB staining.
The positions of SecE, SecG, and his-tagged (hisSecY) and entero-
kinase-cleaved SecY (SecY) are indicated by an arrow.
FIGURE 6: SechYnEG maintains its ability to interact with SecA
when present in octyl glucoside micellar solution. Reconstituted
SechYnEG proteoliposomes (50 íg/mL) (lanes A and B) or
solubilized SechYnEG complex (lanes C and D) was incubated with
0-100 íg/mL SecA and treated with enterokinase for 1 h at 25 °C
as described in the Experimental Procedures section. The amount
of SecA was balanced by BSA at a constant level of 100 íg of
protein/mL, while the samples containing solubilized SechYnEG
complex were supplemented with 1.25% octyl glucoside. Samples
were separated on SDS-15% PAGE and analyzed by Western
blotting using R-SecY (lanes A and C) and R-SecE IgG (lanes B
and D). The latter has been raised against His-tagged SecE and
strongly cross-reacts with the His tag on the SecY protein but not
with SecY.
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determine whether the octyl glucoside-solubilized SechYnEG
supports the formation of this membrane-inserted state, SecA
was radiolabeled with 125I, added to purified SechYnEG
present either in octyl glucoside micellar solution or recon-
stituted in proteoliposomes, and treated with proteinase K
(up to 1 mg/mL). In the presence of AMP-PNP, the
solubilized SechYnEG supported the formation of the 30 kDa
SecA fragment as effectively as proteoliposomes reconsti-
tuted with SechYnEG, and it was about half as active as
urea-treated SechYnEG+ IMVs (Figure 7A). In the absence
of AMP-PNP or SechYnEG, no 30 kDa SecA fragment was
formed. In contrast to octyl glucoside, Triton X-100 did not
support the formation of the 30 kDa fragment (Figure 7B).
Our data demonstrate that octyl glucoside-solubilized
SechYnEG supports the formation of the 125I-labeled 30 kDa
fragment of SecA, which implies that the 30 kDa fragment
is not protected by the lipid phase.
To establish whether the 30 kDa SecA domain is protected
by SechYnEG, samples were also analyzed for remaining
SechYnEG complex. In the absence of SecA and AMP-
PNP, already at low proteinase K concentration (i.e., 10 íg/
mL) both the reconstituted (Figure 8A) and solubilized
SechYnEG (data not shown) were rapidly degraded to
fragments of 6 kDa and smaller that could be visualized by
silver staining. Similar results were obtained by CBB
staining (data not shown) and are in accordance with previous
observations that SecY is highly susceptible to proteolysis
(17). Since the staining assay could not be used for
proteolysis experiments in which SecA was included, two
other approaches were followed, i.e., immunoblot analysis
of the SecY using a pAb directed against the purified SecY
protein (Figure 8B) and autoradiography of 125I-labeled
SechYnEG complex (Figure 8C). At the concentration of
proteinase K (i.e., 1 mg/mL) used to form the 30 kDa SecA
fragment, immunoblotting with the R-SecY IgG revealed that
SecA was unable to prevent proteolysis of SecY, in the
absence or presence of AMP-PNP, either with the SechYnEG
complex reconstituted into proteoliposomes (Figure 8B) or
solubilized in octyl glucoside (data not shown). Although
the pAb presumably recognizes multiple epitopes on SecY,
these are likely confined to the exposed loops of SecY that
are most readily proteolyzed. As an independent assay,
reconstituted SechYnEG was labeled with the nonspecific
lipophilic photoaffinity probe 3-(trifluoromethyl)-3-(m-
iodophenyl)diazirine (TID) that was added in 125I-labeled
form. 125I-TID readily labeled the SecY, SecE, and SecG
proteins (Figure 8C, lane 1). Since only radiochemical
amounts of 125I-TID were used for labeling, photo-cross-
linking had little effect on the SecA translocation ATPase
of the SechYnEG proteoliposomes (data not shown), indicat-
ing that the enzyme has retained most of its activity.
Reconstituted or solubilized 125I-labeled SechYnEG was
completely digested by proteinase K (i.e., 1 mg/mL) yielding
only small fragments (Figure 8C, lanes 2-4 and 6-8). The
fragments are poorly resolved in the lower molecular mass
range due to the presence of 125I-TID-labeled phospholipids
in same region of the tricine gel. An excess of SecA, with
or without AMP-PNP, did not protect the 125I-SechYnEG,
nor did it yield larger protected fragments of SecY (Figure
8C). These data demonstrate that under conditions that the
30 kDa SecA fragment can be formed, the SecYEG is
proteolyzed to fragments of 6 kDa and smaller.
DISCUSSION
In this paper a simple method is described for the rapid
isolation of large quantities (about 5 mg/L of cells) of
homogeneously pure SecYEG protein using IMVs derived
from E. coli cells that overexpress this complex with a
hexahistidine-tagged SecY. The method is based on the
weak anion-exchange column binding characteristics of the
octyl glucoside-solubilized SechYnEG complex. The His
tag on SecY causes a dramatic shift in the elution profile of
the SecYEG complex, such that it elutes in a region which
is essentially free from other contaminants. Wild-type
SecYEG complex elutes from the DEAE column together
with the bulk protein elution (3), and even when overpro-
duced, more than one chromatographic step is needed to
purify the complex (60). Due to the distribution of charges,
the sequence bearing the hexahistidine tag and the entero-
kinase site will have a net negative charge at pH 8.0.
Therefore, tighter instead of weaker binding to the anion-
exchange resin is expected. The reason for this aberrant
chromatographic behavior is unclear. On the other hand,
protocols based on Ni2+ affinity column chromatography
failed to purify the SechYnEG protein as a complex, and
instead only the His-tagged protein is retained by the column
(this paper and ref 26). It thus appears that the subunit
interaction cannot be maintained using Ni2+ affinity column
chromatography, which is either due to the absence of
phospholipids, extensive washing procedures, or both.
The presence of a His tag does not affect the activity of
the SecYEG protein. Translocation and SecA translocation
FIGURE 7: Octyl glucoside-solubilized SechYnEG supports the
AMP-PNP-induced formation of the proteinase K-resistant 30 kDa
125I-SecA fragment. (A) 125I-SecA (2.5 ng/mL) was incubated at 4
°C with SechYnEG+ IMVs (lanes 1-3), SechYnEG proteolipo-
somes (lanes 4-6), octyl glucoside-solubilized SechYnEG (lanes
7-9), or liposomes (lanes 10-12) with and without 1.25 mM AMP-
PNP. Samples containing the solubilized SechYnEG complex were
supplemented with 1.25% octyl glucoside. Subsequently, the amount
of 30 kDa 125I-SecA fragment was determined by incubation for
15 min with various concentrations of proteinase K (0.04, 0.2, and
1 mg/mL) as indicated by the black bars. Samples were precipitated
with 7.5% (w/v) trichloroacetic acid, washed with acetone, solu-
bilized in SDS sample buffer, and analyzed by 12% PAGE and
â-imaging. (B) 125I-SecA (2.5 ng/mL) was incubated at 4 °C with
SechYnEG proteoliposomes (lanes 1 and 2), octyl glucoside- (lane
3) and Triton X-100- (lane 4) solubilized SechYnEG, with (lanes
2-4) or without (lane 1) AMP-PNP. Samples were further treated
as described above.
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ATPase activities of SechYnEG+ IMVs are identical to those
of SecYEG+ IMVs (26). Also, the specificity of the SecYEG
complex appears not to be affected. Unlike proteoliposomes
reconstituted with purified SechYnEG containing a prlA
mutation, SechYnEG proteoliposomes and IMVs are unable
to translocate a signal sequence mutant of proOmpA with a
deletion of Ile at position 8 (A.K. and C.v.d.D., unpublished
results).
As judged from the recovery of SecA translocation ATPase
activity, slightly more than 100% of the total activity
observed with SechYnEG+ IMVs was recovered after
purification. An increase in SecA translocation ATPase
activity was noted before during the purification of the
SecYEG complex from wild-type IMVs (3). When the
mixed orientation of the reconstituted SechYnEG is taken
into account, and assuming that the wrongly oriented
molecules do not contribute to the SecA translocation
ATPase activity, an almost 2-fold increase in total activity
is predicted. These data are normalized to the activity
observed with urea-treated IMVs. Urea treatment largely
inactivates the SecA bound to the translocation sites (29),
and in particular with SechYnEG+ IMVs, a major part of
the SecA protein remains bound to the membranes (24, 49).
It may well be that this SecA blocks translocation sites that
are recovered when the SecA is dissociated from SecYEG
during solubilization and purification. Alternatively, it may
be that urea treatment results in a partial inactivation of the
SecYEG complex. In this respect, we have noted that SecA
readdition to urea-treated IMVs does not completely restore
the translocation activity to the level observed with native
membranes. Taken together, it appears that our purification
methods allows for the isolation of pure SecYEG complex
with a high recovery of activity.
Circular dichroism analysis of the secondary structure of
the SechYnEG reconstituted into liposomes suggests that it
is largely R-helical. The complex encompasses 15 trans-
membrane segments (TMS) that are connected by cytosolic
and periplasmic loops. A high R-helical content is thus
consistent with the predicted secondary structure of the
SecYEG and readily accounts for the presence of 15 R-helical
TMS. There is only a small loss of secondary structure when
the protein is incubated with octyl glucoside or dodecyl
FIGURE 8: SecA and AMP-PNP do not protect SechYnEG against proteolysis by proteinase K. (A) SechYnEG proteoliposomes (100
íg/mL) in 50 mM KCl and 50 mM Tris-HCl, pH 8.0, were incubated for 15 min at 4 °C in the absence (lane 2) or presence (lane 3) of
proteinase K (10 íg/mL). Samples were separated on a 16% Tricine gel and analyzed by silver staining. As a control, the amount of
proteinase K present in the assay was silver-stained (lane 1). The position of hisSecY, SecE, and SecG are indicated. Additional polypeptide
bands in lane 2 are proteolytic degradation products of His-tagged SecY. (B) SechYnEG proteoliposomes (10 íg/mL) (lane 1) were incubated
for 30 min in the translocation buffer D without any additions (lane 2), with 1.25 mM AMP-PNP (lane 3), with 20 íg/mL SecA (lane 4),
or with both SecA and AMP-PNP (lane 5). Samples were subsequently incubated with proteinase K (1 mg/mL) for 15 min at 4 °C, separated
on a 16% Tricine gel, and analyzed by Western blotting using a pAb directed against the purified SecY protein (R-SecY IgG). The positions
of hisSecY and an immunoreactive amino-terminal fragment of hisSecY are indicated. (C) 125I-TID-labeled SechYnEG proteoliposomes
(10 íg/mL) were incubated for 30 min at 4 °C in translocation buffer D in the absence (lanes 1-4) and presence (lanes 5-8) of 1.25%
octyl glucoside. Samples (lanes 2 and 6) were supplemented with 20 íg/mL SecA (lanes 3 and 7) or with both SecA and 1.25 mM AMP-
PNP (lanes 4 and 8). As indicated, samples were treated with proteinase K (1 mg/mL) for 15 min at 4 °C, solubilized in SDS sample buffer,
separated on 16% Tricine gels, and analyzed by autoradiography. The positions of the His-tagged SecY(hisSecY), SecE/G, phospholipids
(PL), and proteolytic fragments are indicated. Molecular mass standards are marked.
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maltoside (C.v.d.D., unpublished data), suggesting that the
complex retains a nearly to native secondary structure when
present in detergent solution. The amino-terminal His tag
on SecY can readily be removed by enterokinase, while SecA
protects SechYn against cleavage when the SechYnEG is
either reconstituted in proteoliposomes or present in detergent
solution. The latter is remarkable as the translocation and
lipid ATPase activity of SecA is (reversibly) inactivated
by detergent (25). In detergent solution approximately
stoichiometric amounts of the SecA monomer relative to
SecY protein are needed for complete protection against
enterokinase digestion. A one-to-one SecA-SecY interac-
tion has been reported in wild-type IMVs (17). The
SechYnEG complex (0.7 íM) was used at a concentration
far above the binding affinity (30 nM) for the SecA
interaction. Therefore, it is not possible to derive a Kd value
from these proteolysis experiments. Since only a slight
excess of SecA is needed relative to SechYnEG complex, it
is evident that the interaction must be of high affinity. SecA
also binds with high affinity to amino-terminal fragments
of SecY on blotting membranes (27).
Octyl glucoside-solubilized SechYnEG not only binds
SecA but also, in the presence of the nonhydrolyzable ATP
analogue, AMP-PNP, supports the formation of the 30 kDa
fragment of 125I-labeled SecA. The 30 kDa fragment
corresponds to a carboxyl-terminal domain of SecA (33) and
is thought to insert into the membrane upon binding of AMP-
PNP (23, 32). We now show that this reaction can be carried
out at 4 °C under conditions that the octyl glucoside-
solubilized SechYnEG is stable. At 37 °C, the complex
rapidly aggregates in detergent solution, and therefore it was
not possible to analyze the formation of 30 kDa SecA
fragment under “translocating” conditions, i.e., in the pres-
ence of ATP and preprotein. Previously, solubilization of
the membranes with Triton X-100 was used as a control to
demonstrate that the 30 kDa proteolytic fragment is a
membrane-integrated SecA domain (32), i.e., in the presence
of Triton X-100, the 30 kDa fragment is readily digested by
proteinase K. Our studies show that, in contrast to octyl
glucoside, Triton X-100 is unable to stabilize the 30 kDa
fragment. Triton X-100 is a more potent detergent as
compared to octyl glucoside due to its lower critical micellar
concentration. It may well be destructive for the SecA-
SecYEG interaction or disrupt the SecA conformation.
Freezing and thawing of the solubilized SechYnEG complex
in the presence of proteinase K did not result in a loss of
the 30 kDa 125I-SecA fragment (C.v.d.D., unpublished
results). Recent studies suggest that the membrane-inserted
form of SecA is not exposed to the lipid phase since it is
inaccessible to lipid-embedded photoaffinity cross-linkers
(61). This has led to the suggestion that the 30 kDa fragment
entirely penetrates the membrane and exposes domains at
the periplasmic membrane face or, alternatively, that it is
shielded from lipid by the SecYEG complex (61, 62). Our
data with the SecYEG complex in octyl glucoside solution
support the finding that the 30 kDa SecA fragment is not
protected against proteinase digestion by the lipid membrane
but also exclude the possibility that it is exposed to a different
compartment, i.e., the periplasmic membrane face of IMVs.
The latter seems also unlikely on the basis of the observation
that AMP-PNP or SecYEG-bound SecA is accessible from
the cytosolic membrane face for binding toward a mAb that
recognizes an epitope which is part of the 30 kDa SecA
fragment (56). Most importantly, the conditions used to form
the SecA fragment result in the complete digestion of the
SecYEG complex, yielding degradation products that are
smaller than 6 kDa. Therefore, it appears that the SecA
fragment is also not protease-protected by a belt of SecYEG
helices. Our data suggest that only small fragments of SecY
suffice to maintain the SecA domain in a protease-resistant
conformation or, alternatively, that the formation of the 30
kDa proteolytic fragment is irreversible. In this respect,
SecA has been shown to bind to SecY fragments that cover
only the 107 amino-terminal residues of the protein (27). It
should be emphasized that the 30 kDa fragment is not unique
for the SecYEG-bound form of SecA, and albeit less stable,
it can also be formed in solution (33). This is an indication
that the 30 kDa fragment might resemble a conformational
state rather than being proteinase-inaccessible. Taken to-
gether, we conclude that the 30 kDa fragment represents a
stable conformation of a SecA domain that is induced by its
interaction with nucleotides and further stabilized by the
SecYEG complex.
Our data do not argue with the hypothesis that SecA drives
preprotein translocation across the membrane by the co-
insertion of a SecA domain and bound preprotein (32) but
demonstrate that any evidence for membrane insertion based
on the formation of a protease-resistant conformation has to
be taken with caution. Recently, it has been shown that SecA
is also proteolyzed into a stable amino-terminal 65 kDa
fragment under exactly the same conditions that result in
the formation of the 30 kDa fragment, i.e., in the presence
of ATP and preprotein or AMP-PNP alone (62) or at low
proteinase concentration in solution (33). Both fragments
cover more than 90% of the molecular mass of SecA, which
is a 102 kDa protein. The 65 kDa fragment bears both of
the nucleotide binding sites of SecA and evidently this part
must be accessible from the cytosol. Since the evidence that
the 65 kDa fragment is membrane-inserted is also based on
proteinase protection experiments, while it is also not
photoaffinity-labeled from the lipid phase (62), its exact
localization requires further investigation. In this respect,
recent studies on the membrane topology of monocysteine
SecA variants indicate that amino-terminal, central, and
carboxy-terminal regions of SecA are periplasmically ac-
cessible to biotin maleimide (63). Biotin maleimide labeling
can be blocked by prior treatment with a membrane-
impermeable cysteine-reactive reagent, suggesting that the
labeling does not occur within the membrane bilayer. These
regions therefore either span the membrane or are located
within a channel that is periplasmically accessible to
molecules the size of biotin maleimide. These data confirm
previous studies on the periplasmic accessibility of the
carboxy-terminal (49) and other regions (64) of SecA to
trypsin. The extreme carboxyl-terminal part of SecA con-
tains the SecB binding domain (31) and dissociates the SecB
upon the initiation of preprotein translocation by binding of
ATP to SecA (31). Since other regions of the carboxyl-
terminal part of SecA interact with SecY (27), it seems that
the carboxyl terminus fullfils a critical role in anchoring of
SecA to the SecYEG heterotrimer during a translocation
cycle. Alternatively to the membrane insertion hypothesis,
polypeptide segments may also be translocated across the
membrane by a mechanism that involves only conformational
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changes (and mechanical movements) of the SecA domains
(30), while they are anchored at the SecYEG complex (49,
63).
Summarizing, the SecYEG complex can now be purified
in large quantities in a functional form and retains many of
its catalytic and functional properties in micellar solution.
This provides the unique opportunity to biochemists and
biophysicists to study the mechanism of preprotein translo-
cation in the absence of compartmentalization.
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